share_log

BridgeBio Pharma | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-KKR Genetic Disorder L.P.(13.4%),KKR Genetic Disorder GP LLC(13.4%), etc.

SEC ·  Sep 17, 2024 18:45
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more